Boosting ferroptosis and microtubule inhibition for antitumor therapy via a carrier-free supermolecule nanoreactor.

Authors:
Mu M; Liang X; Zhao N; Chuan D; Chen B and 6 more

Journal:
J Pharm Anal

Publication Year: 2022

DOI:
10.1016/j.jpha.2022.09.003

PMCID:
PMC9937788

PMID:
36816538

Journal Information

Full Title: J Pharm Anal

Abbreviation: J Pharm Anal

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology & Pharmacy

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"details on encapsulation efficiency (ee) and drug loading (dl) assay can be found in the supplementary data 2 4 mb degradation was performed to detect ?; the methods of cell culture cell uptake and cell cycle assay are shown in the supplementary data 2 7 briefly 3 x 10 3 ct26 cells were seeded into 96-well plates incubated for 12 h added with free doc doc@ta-fe 3+ and doc@ta-fe 3+ + dfo at various concentrations and incubated for another 24 h."

Code Sharing
Evidence found in paper:

"Declaration of competing interest The authors declare that there are no conflicts of interest. Declaration of competing interest"

Evidence found in paper:

"This work was financially supported by the National Natural Science Foundation of China (Grant Nos.: 31971308, 81960769, and U1903211), National S&T Major Project (Grant No.: 2019ZX09301-147), Luzhou Science and Technology Plan (Grant No.: 2018CDLZ-10), and Sichuan Science and Technology Program (Grant No.: 2021YFS0081). Thanks go to www.figdraw.com for the material drawing graphical abstract."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025